Showing 181-190 of 3871 results for "".
MATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: Dr. Jennifer Walden is First Female President of The Aesthetic Society; Plastic Surgeon Residents Face Childcare Issues; ASLMS President Outlines Goals
https://modernaesthetics.com/series/matv-news/matv-news-dr-jennifer-walden-is-first-female-president-of-the-aesthetic-society-plastic-surgeon-residents-face-childcare-issues-aslms-president-outlines-goals/33685/Jennifer Walden, MD discusses her role and goals as the first female president of the Aesthetic Society; a new survey study finds plastic surgeon residents, especially women, face barriers accessing affordable childcare; and Paul Friedman, MD shares plans for his ASLMS presidency, including creatingMATV News: Plastic Surgery Procedures Soared in 2021; Cosmetic Surgery Benefits; Botox Cosmetic Turns 20
https://modernaesthetics.com/series/matv-news/matv-news-plastic-surgery-procedures-soared-in-2021-cosmetic-surgery-benefits-botox-cosmetic-turns-20/33669/The Aesthetic Society’s annual Aesthetic Plastic Surgery Statistics show plastic surgery procedures were on the rise in 2021. Patients dealing with serious illnesses may want cosmetic procedures to make them look healthier. Botox Cosmetic celebrates 20 years since its first FDA approval.MATV News: New HA Fillers Show Promise; HydraFacial Launches Syndeo; AACS Names New President
https://modernaesthetics.com/series/matv-news/matv-news-new-ha-fillers-show-promise-hydrofacial-launches-syndeo-aacs-names-new-president/33666/New HA fillers from Hallura show promise for lips, nasolabial folds, and cheeks. HydraFacial’s Syndeo aims to enhance the consumer and provider experience; and the American Academy of Cosmetic Surgery introduces J. Kevin Duplechain, MD as its new president.MATV News: Revance Wins FDA Nod For Redensity Filler; Obagi Introduces Skintrinsiq, Aesthetic Physicians Cope with Covid-19
https://modernaesthetics.com/series/matv-news/matv-news-revance-wins-fda-nod-for-redensity-filler-obagi-introduces-skintrinsiq-aesthetic-physicians-cope-with-covid-19/33656/FDA Approves Revance’s RHA Redensity filler for perioral rhytids, Obagi enters the device market with introduction of Skintrinsiq, and aesthetic physicians discuss how they’re coping with the recent COVID-19 surge.MATV News: Sculptra Wins Expanded Label; Cutera Introduces truSculpt flex+, AACS Opens Annual Meeting Registration
https://modernaesthetics.com/series/matv-news/matv-news-sculptra-wins-expanded-label-cutera-introduces-trusculpt-flex-aacs-opens-annual-meeting-registration/33653/Galderma’s Sculptra gets an expanded label, Cutera rolls out its next generation muscle-sculpting device—truSculpt flex+, and the American Academy of Cosmetic Surgery opens registration for its annual meeting.MATV News: Thriving in Diversity; Gryphon Acquisition of Revision; Sun Hero Campaign
https://modernaesthetics.com/series/matv-news/matv-news-thriving-in-diversity-gryphon-acquisition-of-revision-sun-hero-campaign/33651/The Thriving in Aesthetics educational series is back for a second season—Thriving in Diversity. Steve Dayan, MD and Sabrina Fabi, MD preview upcoming episodes. Revision Skincare CEO Maria Carell talks about the company’s next steps after its acquisition by Gryphon, and Amy Brodsky, MD wants you toMATV News: Revance Launches OPUL; Science of Skincare Summit Debuts; Restylane is 25; HA Pen Warning
https://modernaesthetics.com/series/matv-news/matv-news-revance-launches-opul-science-of-skincare-summit-debuts-restylane-is-25-ha-pen-warning/33648/A new commerce platform from Revance for aesthetic practices is designed to increase patient loyalty and retention, an upcoming meeting focuses on the science of skincare, Restylane celebrates 25 years on the market, and aesthetic physicians and the FDA warn about a dangerous social media skincare t